| pubmed-article:1512330 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C0340305 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C0018794 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C1522701 | lld:lifeskim |
| pubmed-article:1512330 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:1512330 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1512330 | pubmed:dateCreated | 1992-9-30 | lld:pubmed |
| pubmed-article:1512330 | pubmed:abstractText | The aim of this study was to determine the incidence and significance of second- or third-degree heart block among patients with inferior myocardial infarction treated with thrombolytic therapy. | lld:pubmed |
| pubmed-article:1512330 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1512330 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1512330 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1512330 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1512330 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:1512330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1512330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1512330 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1512330 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:1512330 | pubmed:issn | 0735-1097 | lld:pubmed |
| pubmed-article:1512330 | pubmed:author | pubmed-author:RyanT JTJ | lld:pubmed |
| pubmed-article:1512330 | pubmed:author | pubmed-author:BergerP BPB | lld:pubmed |
| pubmed-article:1512330 | pubmed:author | pubmed-author:FaxonD PDP | lld:pubmed |
| pubmed-article:1512330 | pubmed:author | pubmed-author:JacobsA KAK | lld:pubmed |
| pubmed-article:1512330 | pubmed:author | pubmed-author:FrederickM... | lld:pubmed |
| pubmed-article:1512330 | pubmed:author | pubmed-author:RuoccoN ANAJr | lld:pubmed |
| pubmed-article:1512330 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1512330 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:1512330 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1512330 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1512330 | pubmed:pagination | 533-40 | lld:pubmed |
| pubmed-article:1512330 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:meshHeading | pubmed-meshheading:1512330-... | lld:pubmed |
| pubmed-article:1512330 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1512330 | pubmed:articleTitle | Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. | lld:pubmed |
| pubmed-article:1512330 | pubmed:affiliation | Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905. | lld:pubmed |
| pubmed-article:1512330 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1512330 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1512330 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1512330 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:1512330 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1512330 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1512330 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1512330 | lld:pubmed |
